Navigation Links
Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference
Date:11/25/2008

SAN DIEGO, Nov. 25 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Piper Jaffray 20th Annual Health Care Conference on December 3, 2008 at 2:30 p.m. Eastern Time (11:30 a.m. Pacific Time) at the New York Palace Hotel in New York City. Jack Lief, Arena's President and Chief Executive Officer, is scheduled to provide an overview of the company, including its clinical development and discovery programs.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press relea
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
2. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
3. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
4. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
5. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
6. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
7. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
10. Arena Pharmaceuticals Announces Public Offering of Common Stock
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... 30, 2015 , ... Medflow, the leader in the ophthalmic ... records system from the company exclusively dedicated to helping eye care professionals for ... state-of-the-art solution combining modern cloud technology with Medflow’s proven expertise in the eye ...
(Date:6/30/2015)... ... June 30, 2015 , ... “It is never too ... SunGrubbies.com. “We are particularly interested in getting the word out to children because ... surface. We are extremely pleased with our new video which we feel ...
(Date:6/29/2015)... ... June 30, 2015 , ... The United States ... Team (KORT) as it becomes the Official Physical and Occupational Therapists of the U.S. ... Rolex Kentucky Three-Day Event presented by Land Rover. , “The USEF is pleased ...
(Date:6/29/2015)... ... June 29, 2015 , ... An upcoming documentary for public ... Earl Jones will offer a fresh perspective on conflict in sports with guest ... one of several thought leaders from around the sports industry that will discuss challenges ...
(Date:6/29/2015)... ... June 29, 2015 , ... Healthpointe, one of Southern ... their newest FAA-certified medical examiner in the city of Colton . , ... seeking to obtain their physical aviation certificates. Pilots hoping to navigate airplanes, helicopters, ...
Breaking Medicine News(10 mins):Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 2Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 3Health News:Healthpointe Now Offering FAA Physical Exams in San Bernardino County 2
... By Serena Gordon HealthDay Reporter , WEDNESDAY, Feb. ... called GAD-alum to treat type 1 diabetes failed to show ... sugar disease. The researchers, however, said they felt there ... and that specific groups of people still might benefit from ...
... Feb. 2 (HealthDay News) -- ,Greater use of certain types ... explain why black children,s risk of ischemic stroke dropped significantly ... in stroke-related deaths between black and white children also fell ... 74 percent more likely to die of ischemic stroke than ...
... By Alan Mozes HealthDay Reporter , THURSDAY, ... are exposed to might play a part in determining your ... about how sun may be bad for us, in terms ... an associate professor of biostatistics at the University of Alabama ...
... is associated with a loss of alcohol,s protective effect against ... increase of coronary risk among binge drinkers. ... the Danish National Cohort Study in 1994, 2000, and 2005 ... of IHD or all-cause mortality among "light-to-moderate" drinkers: (up to ...
... Mayo Clinic researchers have found that multiple exposures to ... rates of attention-deficit/hyperactivity disorder (ADHD) . Children exposed ... than double the incidence of ADHD than children who had ... Clinic pediatric anesthesiologist and investigator on the observational study. ...
... , WEDNESDAY, Feb. 1 (HealthDay News) -- ... good, it reduces inflammation in muscles at the cellular ... promote the growth of new mitochondria in skeletal muscle. ... the Buck Institute for Research on Aging and McMaster ...
Cached Medicine News:Health News:Type 1 Diabetes Treatment Disappoints in Trial 2Health News:Type 1 Diabetes Treatment Disappoints in Trial 3Health News:Efforts to Reduce Stroke in Kids With Sickle Cell Working: Study 2Health News:Lack of Sunlight May Raise Stroke Risk 2Health News:The effect of occasional binge drinking on heart disease and mortality among moderate drinkers 2Health News:Young children exposed to anesthesia multiple times show elevated rates of ADHD 2Health News:Science Shows How Massage Eases Sore Muscles 2
(Date:6/29/2015)... June 29, 2015 ... (Troitsk) und Strand Life Sciences, weltweiter Marktführer ... Medizin, haben eine Kooperationsvereinbarung unterzeichnet. Laut Vereinbarung ... entwickeln, basierend auf NGS (Next-Generation Sequencing), für ... Formen von Epilepsie und primären Immundefizenz (PI)-Erkrankungen. ...
(Date:6/29/2015)... N.Y. and EWING, N.J. ...  (Nasdaq: CPXX ) today announced that The Leukemia ... a portion of the final payment linked to the ... lead product candidate, for the treatment of patients with ... moved forward payment of $400,000 originally attached to the ...
(Date:6/29/2015)... MOSCOW , June 29, 2015 /PRNewswire/ ... nanocenter TECHNOSPARK (Troitsk), and Strand Life Sciences, the ... personalized medicine, have signed a cooperation memorandum. According ... develop affordable tests based on next-generation sequencing (NGS) ... hereditary forms of epilepsy and primary immunodeficiency disorders ...
Breaking Medicine Technology:Das Genomic Center of Nanocenters 'Technospark' und 'Dubna', Russland und Strand Life Sciences, Indien werden gemeinsam Tests zur Diagnose von Erbkrankheiten entwickeln 2Das Genomic Center of Nanocenters 'Technospark' und 'Dubna', Russland und Strand Life Sciences, Indien werden gemeinsam Tests zur Diagnose von Erbkrankheiten entwickeln 3The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated with the Phase 3 Study of CPX-351 in High Risk (Secondary) AML 2The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated with the Phase 3 Study of CPX-351 in High Risk (Secondary) AML 3The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated with the Phase 3 Study of CPX-351 in High Risk (Secondary) AML 4The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated with the Phase 3 Study of CPX-351 in High Risk (Secondary) AML 5The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated with the Phase 3 Study of CPX-351 in High Risk (Secondary) AML 6The Genomic Center of Nanocenters 'Technospark' and 'Dubna', Russia and Strand Life Sciences, India to Co-develop Tests for Diagnosis of Inherited Diseases 2The Genomic Center of Nanocenters 'Technospark' and 'Dubna', Russia and Strand Life Sciences, India to Co-develop Tests for Diagnosis of Inherited Diseases 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: